Clinical Trial Page
Clinical Trial Results:
Phase II multicenter, open label, non-randomized study of intravenous RPR109881 q 3 weeks in patients with metastatic breast cancer progressing after therapy with anthracyclines, taxanes, and capecitabine.
| Summary | |
EudraCT number | 2004-000572-14 |
Trial protocol | DK IT ES BE |
Global completion date | 17 Apr 2009 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 05 Jun 2016 |
First version publication date | 05 Jun 2016 |
Other versions | |
Summary report(s) | EFC6088 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.